Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration

Abstract Background Nano-zinc oxide (nZnO) has attracted significant attention in bone tissue engineering due to its antibacterial properties, anti-inflammatory effects, biocompatibility, and chemical stability. Although numerous studies have demonstrated the enhancement of osteogenic differentiatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiu Chen, Zhenkun Weng, Hongchao Zhang, Jian Jiao, Jingjia Liang, Jin Xu, Dongmei Wang, Qian Liu, Qing Yan, Aihua Gu
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-025-04322-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172702491410432
author Xiu Chen
Zhenkun Weng
Hongchao Zhang
Jian Jiao
Jingjia Liang
Jin Xu
Dongmei Wang
Qian Liu
Qing Yan
Aihua Gu
author_facet Xiu Chen
Zhenkun Weng
Hongchao Zhang
Jian Jiao
Jingjia Liang
Jin Xu
Dongmei Wang
Qian Liu
Qing Yan
Aihua Gu
author_sort Xiu Chen
collection DOAJ
description Abstract Background Nano-zinc oxide (nZnO) has attracted significant attention in bone tissue engineering due to its antibacterial properties, anti-inflammatory effects, biocompatibility, and chemical stability. Although numerous studies have demonstrated the enhancement of osteogenic differentiation by nZnO-modified tissue engineering materials, the underlying mechanisms remain poorly characterized. Methods This study aimed to identify the molecular mechanisms how nZnO promoted osteogenic differentiation and bone regeneration using transcriptome analysis, drug intervention, and shRNA knockdown techniques, etc. First, the study evaluated the in vivo effects of gelatin methacryloyl (GelMA) containing nZnO on bone regeneration using a mouse calvarial defect model. The impact of nZnO exposure on the osteogenic differentiation of mesenchymal stem cells (MSCs) was then assessed. The combined treatment of nZnO and MSCs in GelMA for bone regeneration was assessed in the mouse calvarial defect model thereafter. Results nZnO induced osteoblastic differentiation to promote bone regeneration. nZnO activated the AMP-dependent protein kinase (AMPK)-ULK1 signals to stimulate autophagosomes formation and facilitate autophagy flow, which was the essential pathway to induce osteogenic differentiation. The combined treatment of MSCs and nZnO significantly enhanced bone regeneration in calvarial defect mice. Conversely, AMPK inhibitor Compound C (C.C) reversed the effects on autophagy flow and osteogenic potentiality induced by nZnO. Conclusions These results highlight that nZnO can regulate bone regeneration by activating autophagy through the AMPK/ULK1 signaling pathway, which may provide a novel therapeutic strategy for addressing bone defects using nZnO.
format Article
id doaj-art-0e1f7bdea0a341449b63d68ed1ae50ed
institution OA Journals
issn 1757-6512
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-0e1f7bdea0a341449b63d68ed1ae50ed2025-08-20T02:20:01ZengBMCStem Cell Research & Therapy1757-65122025-04-0116111410.1186/s13287-025-04322-5Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regenerationXiu Chen0Zhenkun Weng1Hongchao Zhang2Jian Jiao3Jingjia Liang4Jin Xu5Dongmei Wang6Qian Liu7Qing Yan8Aihua Gu9State Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversitySchool of Medicine, Shanghai East Hospital & Institute of Gallstone Disease, Tongji UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityChangzhou Second People’s Hospital, Changzhou Medical Center, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Nanjing Medical UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityDepartment of Neurosurgery, Children’s Hospital of Nanjing Medical UniversityState Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical UniversityAbstract Background Nano-zinc oxide (nZnO) has attracted significant attention in bone tissue engineering due to its antibacterial properties, anti-inflammatory effects, biocompatibility, and chemical stability. Although numerous studies have demonstrated the enhancement of osteogenic differentiation by nZnO-modified tissue engineering materials, the underlying mechanisms remain poorly characterized. Methods This study aimed to identify the molecular mechanisms how nZnO promoted osteogenic differentiation and bone regeneration using transcriptome analysis, drug intervention, and shRNA knockdown techniques, etc. First, the study evaluated the in vivo effects of gelatin methacryloyl (GelMA) containing nZnO on bone regeneration using a mouse calvarial defect model. The impact of nZnO exposure on the osteogenic differentiation of mesenchymal stem cells (MSCs) was then assessed. The combined treatment of nZnO and MSCs in GelMA for bone regeneration was assessed in the mouse calvarial defect model thereafter. Results nZnO induced osteoblastic differentiation to promote bone regeneration. nZnO activated the AMP-dependent protein kinase (AMPK)-ULK1 signals to stimulate autophagosomes formation and facilitate autophagy flow, which was the essential pathway to induce osteogenic differentiation. The combined treatment of MSCs and nZnO significantly enhanced bone regeneration in calvarial defect mice. Conversely, AMPK inhibitor Compound C (C.C) reversed the effects on autophagy flow and osteogenic potentiality induced by nZnO. Conclusions These results highlight that nZnO can regulate bone regeneration by activating autophagy through the AMPK/ULK1 signaling pathway, which may provide a novel therapeutic strategy for addressing bone defects using nZnO.https://doi.org/10.1186/s13287-025-04322-5nZnOAutophagyBone regeneration
spellingShingle Xiu Chen
Zhenkun Weng
Hongchao Zhang
Jian Jiao
Jingjia Liang
Jin Xu
Dongmei Wang
Qian Liu
Qing Yan
Aihua Gu
Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
Stem Cell Research & Therapy
nZnO
Autophagy
Bone regeneration
title Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
title_full Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
title_fullStr Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
title_full_unstemmed Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
title_short Nano-zinc oxide (nZnO) targets the AMPK-ULK1 pathway to promote bone regeneration
title_sort nano zinc oxide nzno targets the ampk ulk1 pathway to promote bone regeneration
topic nZnO
Autophagy
Bone regeneration
url https://doi.org/10.1186/s13287-025-04322-5
work_keys_str_mv AT xiuchen nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT zhenkunweng nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT hongchaozhang nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT jianjiao nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT jingjialiang nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT jinxu nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT dongmeiwang nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT qianliu nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT qingyan nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration
AT aihuagu nanozincoxidenznotargetstheampkulk1pathwaytopromoteboneregeneration